近視治療機器の世界市場：洞察、競合情勢、市場予測：2030年

世界の近視治療機器の市場規模は、2024年から2030年までの予測期間中に7.57％のCAGRで拡大すると予測されています。近視治療機器に対する需要の増加は、世界中で近視の有病率が上昇していることが主な原因です。さらに、近視治療機器の普及率の増加も、これらの機器の需要を強化し、今後数年間の近視治療機器市場の拡大につながると予想されます。さらに、様々な高度近視管理デバイスの製品発売の増加や、近視治療に関する国民の意識を高めるための政府のイニシアティブの高まりも、予測期間中にこれらのデバイスの需要に拍車をかけると予想されます。

近視治療機器市場は、世界中で近視患者が増加していることから、現在急成長しています。世界保健機関（WHO）によると、近視は未矯正の屈折異常の一種で、患者の視力障害の最も一般的な原因です。また、近視は白内障や緑内障のリスクが高いです。さらに、WHOの予測によると、近視と強度近視は、2050年までにそれぞれ世界人口の52％（49億4,900万人）と10.0％（9億2,500万人）に影響を及ぼすとされています。

また、オーストラリア政府が2023年に発表したデータによると、同国では2017年から2018年の間に約630万人が近視の影響を受けています。同様の動向は、世界中の他の国々でも観察されると予想され、予測期間中に近視用治療装置の需要を高める可能性が高いとみられています。

当レポートでは、世界の近視治療機器市場について調査し、市場の概要とともに、治療別、製品タイプ別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 近視治療機器市場レポートのイントロダクション

第2章 近視治療機器市場のエグゼクティブサマリー

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 近視治療機器市場の主な要因分析

• 近視治療機器市場の促進要因
• 近視治療機器市場の抑制要因と課題
• 近視治療機器市場の機会

第5章 近視治療機器市場におけるポーターのファイブフォース分析

第6章 近視治療機器市場に対するCOVID-19の影響分析

第7章 近視治療機器市場概要

• 治療別
• 製品タイプ別
• エンドユーザー別
• 地域別

第8章 近視治療機器の世界企業シェア分析-主要3～5社

第9章 近視治療機器の企業と製品プロファイル

• CooperVision
• Johnson & Johnson
• Essilor
• Bausch & Lomb Incorporated
• Menicon Co., Ltd.
• LUCID KOREA LTD.
• HOYA VISION CARE COMPANY
• SynergEyes.
• SightGlass Vision, Inc.
• Ophtec BV
• STAAR SURGICAL
• Mark'ennovy
• SCHWIND eye-tech-solutions
• Euclid Systems Corporation
• NIDEK USA, Inc.
• HORUS S.n.C. di Risoldi & C - P
• Alcon Inc.
• Falco lenses AG

第10章 KOL の見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis on Myopia Treatment Devices Market
• Table 3: Myopia Treatment Devices Market Analysis in Global (2021-2030)
• Table 4: Myopia Treatment Devices Market Analysis in Global by Treatment (2021-2030)
• Table 5: Myopia Treatment Devices Market Analysis in Global by Product Type (2021-2030)
• Table 6: Myopia Treatment Devices Market Analysis in Global by End User (2021-2030)
• Table 7: Myopia Treatment Devices Market Analysis in Global by Geography (2021-2030)
• Table 8: Myopia Treatment Devices Market Analysis in North America (2021-2030)
• Table 9: Myopia Treatment Devices Market Analysis in North America by Treatment (2021-2030)
• Table 10: Myopia Treatment Devices Market Analysis in North America by Product Type (2021-2030)
• Table 11: Myopia Treatment Devices Market Analysis in North America by End User (2021-2030)
• Table 12: Myopia Treatment Devices Market Analysis in North America by Country (2021-2030)
• Table 13: Myopia Treatment Devices Market Analysis in the US (2021-2030)
• Table 14: Myopia Treatment Devices Market Analysis in Canada (2021-2030)
• Table 15: Myopia Treatment Devices Market Analysis in Mexico (2021-2030)
• Table 16: Myopia Treatment Devices Market Analysis in Europe (2021-2030)
• Table 17: Myopia Treatment Devices Market Analysis in Europe by Treatment (2021-2030)
• Table 18: Myopia Treatment Devices Market Analysis in Europe by Product Type (2021-2030)
• Table 19: Myopia Treatment Devices Market Analysis in Europe by End User (2021-2030)
• Table 20: Myopia Treatment Devices Market Analysis in Europe by Country (2021-2030)
• Table 21: Myopia Treatment Devices Market Analysis in France (2021-2030)
• Table 22: Myopia Treatment Devices Market Analysis in Germany (2021-2030)
• Table 23: Myopia Treatment Devices Market Analysis in the UK (2021-2030)
• Table 24: Myopia Treatment Devices Market Analysis in Italy (2021-2030)
• Table 25: Myopia Treatment Devices Market Analysis in Spain (2021-2030)
• Table 26: Myopia Treatment Devices Market Analysis in Russia (2021-2030)
• Table 27: Myopia Treatment Devices Market Analysis in Rest of Europe (2021-2030)
• Table 28: Myopia Treatment Devices Market Analysis in Asia-Pacific (2021-2030)
• Table 29: Myopia Treatment Devices Market Analysis in Asia-Pacific by Treatment (2021-2030)
• Table 30: Myopia Treatment Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
• Table 31: Myopia Treatment Devices Market Analysis in Asia-Pacific by End User (2021-2030)
• Table 32: Myopia Treatment Devices Market Analysis in Asia-Pacific by Country (2021-2030)
• Table 33: Myopia Treatment Devices Market Analysis in China (2021-2030)
• Table 34: Myopia Treatment Devices Market Analysis in Japan (2021-2030)
• Table 35: Myopia Treatment Devices Market Analysis in India (2021-2030)
• Table 36: Myopia Treatment Devices Market Analysis in Australia (2021-2030)
• Table 37: Myopia Treatment Devices Market Analysis in South Korea (2021-2030)
• Table 38: Myopia Treatment Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
• Table 39: Myopia Treatment Devices Market Analysis in Rest of World (2021-2030)
• Table 40: Myopia Treatment Devices Market Analysis in Rest of World by Treatment (2021-2030)
• Table 41: Myopia Treatment Devices Market Analysis in Rest of World by Product Type (2021-2030)
• Table 42: Myopia Treatment Devices Market Analysis in Rest of World by End User (2021-2030)
• Table 43: Myopia Treatment Devices Market Analysis in Rest of World by Country (2021-2030)
• Table 44: Myopia Treatment Devices Market Analysis in the Middle East (2021-2030)
• Table 45: Myopia Treatment Devices Market Analysis in Africa (2021-2030)
• Table 46: Myopia Treatment Devices Market Analysis in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis on Myopia Treatment Devices Market
• Figure 3: Myopia Treatment Devices Market Analysis in Global (2021-2030)
• Figure 4: Myopia Treatment Devices Market Analysis in Global by Treatment (2021-2030)
• Figure 5: Myopia Treatment Devices Market Analysis in Global by Product Type (2021-2030)
• Figure 6: Myopia Treatment Devices Market Analysis in Global by End User (2021-2030)
• Figure 7: Myopia Treatment Devices Market Analysis in Global by Geography (2021-2030)
• Figure 8: Myopia Treatment Devices Market Analysis in North America (2021-2030)
• Figure 9: Myopia Treatment Devices Market Analysis in North America by Treatment (2021-2030)
• Figure 10: Myopia Treatment Devices Market Analysis in North America by Product Type (2021-2030)
• Figure 11: Myopia Treatment Devices Market Analysis in North America by End User (2021-2030)
• Figure 12: Myopia Treatment Devices Market Analysis in North America by Country (2021-2030)
• Figure 13: Myopia Treatment Devices Market Analysis in the US (2021-2030)
• Figure 14: Myopia Treatment Devices Market Analysis in Canada (2021-2030)
• Figure 15: Myopia Treatment Devices Market Analysis in Mexico (2021-2030)
• Figure 16: Myopia Treatment Devices Market Analysis in Europe (2021-2030)
• Figure 17: Myopia Treatment Devices Market Analysis in Europe by Treatment (2021-2030)
• Figure 18: Myopia Treatment Devices Market Analysis in Europe by Product Type (2021-2030)
• Figure 19: Myopia Treatment Devices Market Analysis in Europe by End User (2021-2030)
• Figure 20: Myopia Treatment Devices Market Analysis in Europe by Country (2021-2030)
• Figure 21: Myopia Treatment Devices Market Analysis in France (2021-2030)
• Figure 22: Myopia Treatment Devices Market Analysis in Germany (2021-2030)
• Figure 23: Myopia Treatment Devices Market Analysis in the UK (2021-2030)
• Figure 24: Myopia Treatment Devices Market Analysis in Italy (2021-2030)
• Figure 25: Myopia Treatment Devices Market Analysis in Spain (2021-2030)
• Figure 26: Myopia Treatment Devices Market Analysis in Russia (2021-2030)
• Figure 27: Myopia Treatment Devices Market Analysis in Rest of Europe (2021-2030)
• Figure 28: Myopia Treatment Devices Market Analysis in Asia-Pacific (2021-2030)
• Figure 29: Myopia Treatment Devices Market Analysis in Asia-Pacific by Treatment (2021-2030)
• Figure 30: Myopia Treatment Devices Market Analysis in Asia-Pacific by Product Type (2021-2030)
• Figure 31: Myopia Treatment Devices Market Analysis in Asia-Pacific by End User (2021-2030)
• Figure 32: Myopia Treatment Devices Market Analysis in Asia-Pacific by Country (2021-2030)
• Figure 33: Myopia Treatment Devices Market Analysis in China (2021-2030)
• Figure 34: Myopia Treatment Devices Market Analysis in Japan (2021-2030)
• Figure 35: Myopia Treatment Devices Market Analysis in India (2021-2030)
• Figure 36: Myopia Treatment Devices Market Analysis in Australia (2021-2030)
• Figure 37: Myopia Treatment Devices Market Analysis in South Korea (2021-2030)
• Figure 38: Myopia Treatment Devices Market Analysis in Rest of Asia-Pacific (2021-2030)
• Figure 39: Myopia Treatment Devices Market Analysis in Rest of World (2021-2030)
• Figure 40: Myopia Treatment Devices Market Analysis in Rest of World by Treatment (2021-2030)
• Figure 41: Myopia Treatment Devices Market Analysis in Rest of World by Product Type (2021-2030)
• Figure 42: Myopia Treatment Devices Market Analysis in Rest of World by End User (2021-2030)
• Figure 43: Myopia Treatment Devices Market Analysis in Rest of World by Country (2021-2030)
• Figure 44: Myopia Treatment Devices Market Analysis in the Middle East (2021-2030)
• Figure 45: Myopia Treatment Devices Market Analysis in Africa (2021-2030)
• Figure 46: Myopia Treatment Devices Market Analysis in South America (2021-2030)
• Figure 47: Market Drivers
• Figure 48: Market Barriers
• Figure 49: Market Opportunities
• Figure 50: PORTER's Five Force Analysis

Myopia Treatment Devices Market By Treatment (Corrective Lenses, Laser Eye Surgery, Lens Implant Surgery), By Product Type (Eyeglasses, Contact Lenses, Ortho-K Lenses, Phakic Intraocular Lenses, Excimer Laser Refractive Surgery Devices), By End-User (Hospitals, Specialty Clinics, And Others), by geography, is projected to grow at a noteworthy CAGR forecast till 2030 owing to the growing burden of myopia across the globe and high adoption rate of myopia treatment devices

The global myopia treatment devices market is growing at a CAGR of 7.57% during the forecast period from 2024 to 2030. The increase in demand for myopia treatment devices is predominantly due to the rising prevalence of myopia across the globe. Moreover, an increase in the adoption rate of myopia treatment devices is also expected to bolster the demand for these devices thereby leading to an increased market of myopia treatment devices in the upcoming years. Furthermore, an increase in product launches of various advanced myopia management devices and rising government initiatives to raise awareness among the population regarding myopia treatment are also anticipated to spur the demand for these devices during the forecasted period.

Myopia Treatment Devices Market Dynamics:

The market for myopia treatment devices is gaining pace at present owing to the growing myopia cases across the globe. According to the World Health Organization (WHO), myopia is a type of uncorrected refractive error that is the most common cause of vision impairment among patients. Also, myopia is associated with a higher risk of cataracts and glaucoma. Moreover, as per the projections mentioned by the WHO, myopia and high myopia would affect 52% (4949 million) and 10.0% (925 million), respectively, of the world's population by the year 2050.

In addition, as per the data published by the Australian Government in the year 2023, approximately 6.3 million people in the country were affected with short-sightedness (myopia) between the years 2017-2018. Similar trends are expected to be observed in other countries across the globe which is likely to raise the demand for treatment devices for myopia during the forecasted period.

Furthermore, approval of various myopia treatment devices in various countries across the globe to slow down the progression of the disease is also projected to augment the market in the upcoming years. For instance, on June 03, 2020, SightGlass Vision achieved CE Mark allowing European Marketing Authorization for novel eyeglasses that slow myopia progression in children. The spectacles developed by the company comprise advanced diffusion optics technology spectacle lenses.

Hence, the above-mentioned factors are expected to increase the market for myopia management devices in the following years.

However, limitations associated with the refractive surgery procedures and stringent regulatory approval process for the myopia treatment devices are likely to impede the growth of the myopia treatment devices market.

The unprecedented COVID-19 impact had sluggish the market growth for myopia treatment devices. This is due to the implementation of stringent lockdowns across the nation, reduction in clinic visits due to reluctance among patients during the pandemic, among others. However, a sudden shift towards digital or e-learning approaches from classroom-based learning has subsequently increased myopia and its progression among the students. For instance, as per the report published by UNESCO in the year 2020, approximately 1.37 billion students from more than 130 countries globally were affected by the pandemic as the schools and universities adopted digital learning during the pandemic to curb the infection. Thus, it is expected to increase the risk of myopia among the children which will increase the demand for the myopia treatment devices during the post-pandemic situation, thus the market will gain normalcy.

Myopia Treatment Devices Market Segment Analysis:

Myopia Treatment Devices Market By Treatment (Corrective Lenses, Laser Eye Surgery, Lens Implant Surgery), By Product Type (Eye Glasses, Contact Lenses, Ortho-K Lenses, Phakic Intraocular Lenses, Excimer Laser Refractive Surgery Devices), By End-User (Hospitals, Specialty Clinics, and Others), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of myopia treatment devices, the contact lenses segment is expected to hold a significant market share during the forecasted period. This is due to their wide availability and cost-effectiveness. Additionally, contact lenses allow a natural field of view, have no frames to obstruct the vision, and greatly reduce distortions. Unlike glasses, they do not fog up or get splattered by mud or rain. Thus, the benefits associated with contact lenses are likely to boost the segment market. Furthermore, as per the CDC, some contact lenses can also provide extra UV protection.

Also, the rising focus of various companies towards developing technologically advanced myopia treating contact lenses is likely to upsurge the segmental market. For instance, on January 19, 2022, CooperVision Specialty EyeCare began offering 5 mm back optic zone diameter (BOZD) customization for Paragon CRT® and Paragon CRT Dual Axis® contact lenses. The new option joined several existing customization choices, further expanding myopia management possibilities for eye care professionals.

Moreover, approval of various contact lenses for better management of myopia progression is also a potential factor contributing to the market growth of contact lenses for myopia treatment. For instance, on September 08, 2022, Johnson & Johnson Vision received approval from Health Canada for ACUVUE® Abiliti(TM) 1-Day Soft therapeutic lenses for myopia management. These lenses are specifically designed for children who are 7 to 12 years old at the start of treatment.

Thus, the interplay of all the aforementioned factors is projected to bolster the myopia treatment devices market in the forthcoming years.

Asia Pacific is expected to witness the fastest growth in the overall Myopia Treatment Devices Market:

Among all the regions, Asia Pacific is anticipated to register the fastest growth in the myopia treatment devices market during the forecasted period. This is owing to the rising prevalence of the targeted population. For instance, according to the report published by the Government of Singapore in the year 2019, the prevalence of myopia in Singapore is among the highest in the world, with 65% of children being myopic by 6, and 83% of young adults being myopic. Also, Singapore is often labelled as the "Myopia Capital of the World". It is projected that 80 to 90% of all Singaporean adults above 18 years old would be myopic and 15 to 25% of these individuals may have high myopia by the year 2050.

Moreover, rising government initiatives to raise awareness regarding the proper management of myopia among the population in the region is also a potential factor for market growth. For instance, in support of the UN resolution "Eye health for all by 2030", and to create public awareness on eye care, the Optometry Council of India (OCI) started a screening initiative on the occasion of World Sight Day (WSD) with 100,000 screenings in 100 days from 1st September 2022. OCI would also be releasing an awareness film on myopia and what interventions can be done to prevent myopia and myopic progression.

Furthermore, the presence of regional companies such as Menicon Co., Ltd., Kubota Pharmaceutical Holdings Co., Ltd., among others, and their increased focus towards developing novel myopia treatment market will also contribute to the fastest market growth in the region.

For instance, Kubota Pharmaceutical Holdings Co., Ltd. with its subsidiary Kubota Vision is planning to use the Kubota Glass technology which leverages nanotechnology in an electronic glasses-based device to reduce the progression of myopia by actively stimulating the retina for shorter periods while maintaining high-quality central vision and not affecting daily activities to develop smart contact lenses for the reduction of myopia progression.

Thus, all the above-mentioned factors would contribute to the regional market growth of myopia treatment devices during the forecasted period.

Myopia Treatment Devices Market Key Players:

Some of the key market players operating in the Myopia Treatment Devices market include CooperVision (CooperCompanies), Johnson & Johnson, Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes., SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., HORUS S.n.C. di Risoldi & C - P, Falco lenses AG, and others.

Recent Developmental Activities in the Myopia Treatment Devices Market:

On May 25, 2022, CooperVision DreamLite® Ortho-K Lenses gained European approval for slowing the progression of myopia.

On May 12, 2022, Euclid Systems Corporation, a global leader in advanced orthokeratology and proactive myopia management, launched the latest breakthrough in overnight orthokeratology lens, Euclid MAX in the US.

On April 07, 2022, Menicon entered into a global collaboration with Johnson & Johnson Vision to bring forward therapeutic contact lens-related products and services to manage the progression of myopia in children.

Key Takeaways from the Myopia Treatment Devices Market Report Study

• Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Myopia Treatment Devices market.
• Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
• Key companies dominating the Global Myopia Treatment Devices Market.
• Various opportunities available for the other competitor in the Myopia Treatment Devices Market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for Myopia Treatment Devices market growth in the coming future?

Target Audience who can be benefited from the Myopia Treatment Devices Market Report Study

• Myopia Treatment Devices providers
• Research organizations and consulting companies
• Myopia Treatment Devices-related organization, association, forum, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders in Myopia Treatment Devices
• Various End-users who want to know more about the Myopia Treatment Devices Market and the latest technological developments in the Myopia Treatment Devices market.

Frequently Asked Questions for the Myopia Treatment Devices Market:

1. What are Myopia Treatment Devices?

Myopia, or nearsightedness, is a refractive vision disorder that causes blurred sight at a distance. It occurs when the length of the eye (known as axial length) is too great; myopia progresses as axial length increases with age. The devices such as eyeglasses, contact lenses, Ortho-K lenses, among others which are used to slow down the progression of myopia are termed as myopia treatment devices.

2. What is the market for Global Myopia Treatment Devices?

The global myopia treatment devices market is growing at a CAGR of 7.57% during the forecast period from 2024 to 2030.

3. What are the drivers for the Global Myopia Treatment Devices?

The major factor driving the demand for Myopia Treatment Devices is the rising burden of myopia across the globe. In addition, an increase in the adoption rate of myopia treatment devices is also expected to bolster the demand for these devices thereby leading to an increased market of myopia treatment devices in the upcoming years. Additionally, the rise in product launches of various advanced myopia management devices and rising government initiatives to raise awareness among the population regarding myopia treatment are also anticipated to spur the demand for these devices during the forecasted period.

4. What are the key players operating in Global Myopia Treatment Devices?

Some of the key market players operating in the Myopia Treatment Devices market include CooperVision (CooperCompanies), Johnson & Johnson, Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes., SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., HORUS S.n.C. di Risoldi & C - P, Falco lenses AG, and others.

5. Which region has the fastest growth in the Myopia Treatment Devices market?

Among all the regions, Asia Pacific is anticipated to register the fastest growth in the myopia treatment devices market during the forecasted period. This is owing to the rising prevalence of the targeted population. Moreover, rising government initiatives to raise awareness regarding the proper management of myopia among the population in the region is also a potential factor for market growth. Furthermore, the presence of regional companies and rising disposable income, and improving the healthcare system in the region would also lead to the fastest growth.

Table of Contents

1.Myopia Treatment Devices Market Report Introduction

2.Myopia Treatment Devices Market Executive summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment
• 2.4. Financial Benchmarking

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Myopia Treatment Devices Market Key factors analysis

• 4.1. Myopia Treatment Devices Market Drivers
  • 4.1.1. The rising prevalence of myopia
  • 4.1.2. Growing approval and product launches of various Myopia Treatment Devices
  • 4.1.3. Rising awareness regarding myopia treatment
• 4.2. Myopia Treatment Devices Market Restraints and Challenges
  • 4.2.1. Limitations associated with refractive surgery procedures
  • 4.2.2. The stringent regulatory approval process
• 4.3. Myopia Treatment Devices Market Opportunities
  • 4.3.1. Low and middle-income nations have tremendous opportunities for the Myopia Treatment Devices market
  • 4.3.2. Strategic business activities by the global as well as regional manufacturers will provide opportunities in the Myopia Treatment Devices market

5. Myopia Treatment Devices Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Myopia Treatment Devices Market

7. Myopia Treatment Devices Market layout

• 7.1. By Treatment
  • 7.1.1. Corrective lenses
  • 7.1.2. Laser Eye Surgery
  • 7.1.3. Lens Implant Surgery
• 7.2. By Product Type
  • 7.2.1. Eye Glasses
  • 7.2.2. Contact Lenses
  • 7.2.3. Ortho-k lenses
  • 7.2.4. Phakic Intraocular Lenses
  • 7.2.5. Excimer Laser Refractive Surgery Devices
• 7.3. By End-User
  • 7.3.1. Hospitals
  • 7.3.2. Specialty Clinics
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America
    • 7.4.1.1. North America Myopia Treatment Devices Market, by Treatment
    • 7.4.1.2. North America Myopia Treatment Devices Market, by Product Type
    • 7.4.1.3. North America Myopia Treatment Devices Market, by End User
    • 7.4.1.4. North America Myopia Treatment Devices Market, by Country
    • 7.4.1.4.1. United States
    • 7.4.1.4.2. Canada
    • 7.4.1.4.3. Mexico
  • 7.4.2. Europe
    • 7.4.2.1. Europe Myopia Treatment Devices Market, by Treatment
    • 7.4.2.2. Europe Myopia Treatment Devices Market, by Product Type
    • 7.4.2.3. Europe Myopia Treatment Devices Market, by End User
    • 7.4.2.4. Europe Myopia Treatment Devices Market, by Country
    • 7.4.2.4.1. France
    • 7.4.2.4.2. Germany
    • 7.4.2.4.3. United Kingdom
    • 7.4.2.4.4. Italy
    • 7.4.2.4.5. Spain
    • 7.4.2.4.6. Russia
    • 7.4.2.4.7. Rest of Europe
  • 7.4.3. Asia-Pacific
    • 7.4.3.1. Asia-Pacific Myopia Treatment Devices Market, by Treatment
    • 7.4.3.2. Asia-Pacific Myopia Treatment Devices Market, by Product Type
    • 7.4.3.3. Asia-Pacific Myopia Treatment Devices Market, by End User
    • 7.4.3.4. Asia-Pacific Myopia Treatment Devices Market, by Country
    • 7.4.3.4.1. China
    • 7.4.3.4.2. Japan
    • 7.4.3.4.3. India
    • 7.4.3.4.4. Australia
    • 7.4.3.4.5. South Korea
    • 7.4.3.4.6. Rest of Asia Pacific
  • 7.4.4. Rest of the World (RoW)
    • 7.4.4.1. RoW Myopia Treatment Devices Market, by Treatment
    • 7.4.4.2. RoW Myopia Treatment Devices Market, by Product T
    • 7.4.4.3. RoW Myopia Treatment Devices Market, by End User
    • 7.4.4.4. RoW Myopia Treatment Devices Market, by Region
    • 7.4.4.4.1. Middle East
    • 7.4.4.4.2. Africa
    • 7.4.4.4.3. South America

8. Myopia Treatment Devices Global Company Share Analysis - Key 3-5 Companies

9. Myopia Treatment Devices Company and Product Profiles

• 9.1. CooperVision (CooperCompanies)
  • 9.1.1. Company Overview
  • 9.1.2. Company Snapshot
  • 9.1.3. Financial Overview
  • 9.1.4. Product Listing
  • 9.1.5. Entropy
• 9.2. Johnson & Johnson
  • 9.2.1. Company Overview
  • 9.2.2. Company Snapshot
  • 9.2.3. Financial Overview
  • 9.2.4. Product Listing
  • 9.2.5. Entropy
• 9.3. Essilor
  • 9.3.1. Company Overview
  • 9.3.2. Company Snapshot
  • 9.3.3. Financial Overview
  • 9.3.4. Product Listing
  • 9.3.5. Entropy
• 9.4. Bausch & Lomb Incorporated
  • 9.4.1. Company Overview
  • 9.4.2. Company Snapshot
  • 9.4.3. Financial Overview
  • 9.4.4. Product Listing
  • 9.4.5. Entropy
• 9.5. Menicon Co., Ltd.
  • 9.5.1. Company Overview
  • 9.5.2. Company Snapshot
  • 9.5.3. Financial Overview
  • 9.5.4. Product Listing
  • 9.5.5. Entropy
• 9.6. LUCID KOREA LTD.
  • 9.6.1. Company Overview
  • 9.6.2. Company Snapshot
  • 9.6.3. Financial Overview
  • 9.6.4. Product Listing
  • 9.6.5. Entropy
• 9.7. HOYA VISION CARE COMPANY
  • 9.7.1. Company Overview
  • 9.7.2. Company Snapshot
  • 9.7.3. Financial Overview
  • 9.7.4. Product Listing
  • 9.7.5. Entropy
• 9.8. SynergEyes.
  • 9.8.1. Company Overview
  • 9.8.2. Company Snapshot
  • 9.8.3. Financial Overview
  • 9.8.4. Product Listing
  • 9.8.5. Entropy
• 9.9. SightGlass Vision, Inc.
  • 9.9.1. Company Overview
  • 9.9.2. Company Snapshot
  • 9.9.3. Financial Overview
  • 9.9.4. Product Listing
  • 9.9.5. Entropy
• 9.10. Ophtec BV
  • 9.10.1. Company Overview
  • 9.10.2. Company Snapshot
  • 9.10.3. Financial Overview
  • 9.10.4. Product Listing
  • 9.10.5. Entropy
• 9.11. STAAR SURGICAL
  • 9.11.1. Company Overview
  • 9.11.2. Company Snapshot
  • 9.11.3. Financial Overview
  • 9.11.4. Product Listing
  • 9.11.5. Entropy
• 9.12. Mark'ennovy
  • 9.12.1. Company Overview
  • 9.12.2. Company Snapshot
  • 9.12.3. Financial Overview
  • 9.12.4. Product Listing
  • 9.12.5. Entropy
• 9.13. SCHWIND eye-tech-solutions
  • 9.13.1. Company Overview
  • 9.13.2. Company Snapshot
  • 9.13.3. Financial Overview
  • 9.13.4. Product Listing
  • 9.13.5. Entropy
• 9.14. Euclid Systems Corporation
  • 9.14.1. Company Overview
  • 9.14.2. Company Snapshot
  • 9.14.3. Financial Overview
  • 9.14.4. Product Listing
  • 9.14.5. Entropy
• 9.15. NIDEK USA, Inc.
  • 9.15.1. Company Overview
  • 9.15.2. Company Snapshot
  • 9.15.3. Financial Overview
  • 9.15.4. Product Listing
  • 9.15.5. Entropy
• 9.16. HORUS S.n.C. di Risoldi & C - P
  • 9.16.1. Company Overview
  • 9.16.2. Company Snapshot
  • 9.16.3. Financial Overview
  • 9.16.4. Product Listing
  • 9.16.5. Entropy
• 9.17. Alcon Inc.
  • 9.17.1. Company Overview
  • 9.17.2. Company Snapshot
  • 9.17.3. Financial Overview
  • 9.17.4. Product Listing
  • 9.17.5. Entropy
• 9.18. Falco lenses AG
  • 9.18.1. Company Overview
  • 9.18.2. Company Snapshot
  • 9.18.3. Financial Overview
  • 9.18.4. Product Listing
  • 9.18.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us